Synthalis

London, United Kingdom

AI drug discovery Drug Discovery Drug Development Therapeutics

An AI-native pharmaceutical company transforming scientific innovation from Africa and the UK into high-impact global health solutions. By combining cutting-edge artificial intelligence with regional biomedical expertise, we accelerate drug discovery and development—turning underutilized insights into scalable therapeutic assets. Our mission is to close the innovation gap, reduce R&D timelines, and deliver next-generation treatments to patients worldwide.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Synthalis on @MedStartr Today #AllTherapeuticAreas #AIDrugDiscovery #DrugDiscovery #DrugDevelopment #Therapeutics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/jzx8WiB5S_Y

Get Involved in Synthalis

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2025
Website: synthalis.com/

Disease Areas

All Therapeutic Areas

Technologies

AI/Machine LearningAI-driven Drug DiscoveryComputational Drug DiscoveryDrug Discovery Tech

🌐Website

What do you think of Synthalis?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.